← Evidence map

ArticleDiabetes technology & therapeutics2017

Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use.

Nadine Taleb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2017
2018
2019
2020
2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28846447